Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate...
Significant milestone in Dimerix’s Phase 3 trial on kidney disease, with first patient recruited
Startup Clerkenwell Health hopes to help make UK a world leader in psychedelics research
Surveys undertaken with global pharma in 2018 and 2021 show an impressive turnaround of opinion on the attractiveness of the UK for research and medicines launches over the past three years. Angela McFarlane interprets the results - Magazine Article - PharmaTimes
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.